Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT SHPT: Paricalcitol vs Cinacalcet in Hemodialysis Patients
NCT00977080Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 4 trial of paricalcitol oral solution in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Nov 2009; status: completed.
02
Drugs
paricalcitol oral solution
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00977080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977080.